Their role in dermatology practice

Journal of Drugs in Dermatology, Oct, 2003 by Neil S Sadick

(44.) Gensler HL, Williams T, Huang AC, et al. Oral niacin prevents photocarcinogenesis and photoimmunosuppression in mice, Nutr Cancer 1999; 34(1):36-41.

(45.) Kim H. Kim M. Quasem JG, et al. A topical niacin prodrug for skin cancer prevention. Proc Am Assoc Cancer Res 2002; 43:1144.

(46.) Tanno O, Ota Y, Kitamura N, et a. Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier. Br J Dermatol 2000; 143:524-531.

(47.) Hakozaki T. Minwalla L, Zhuang J, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol 2002; 147:20-31.

(48.) Bissett DL. Oblong JE. Saud A, et al. Topical niacinamide provides improvement in aging human facial skin. Poster presented at: Annual Meeting of the American Academy of Dermatology 2002; New Orleans, LA.

(49.) Perricone N. Topical alpha lipoic acid for anti-aging. Skin & Aging May 1998; 17-19.

(50.) Perricone NV. Topical 5% alpha lipoic acid cream in the treatment of cutaneous rhytids. Aesthetic Surg J 2000; 20:219-222.

(51.) Podda M, Rallis M, Traber MG, et al. Kinetic study of cutaneous and subcutaneous distribution following topical application of(7.8-14C) rac-alpha lipoic acid onto hairless mice. Biochem Pharmacol 1996; 52:627-633.

(52.) Ghosh D, Murthy U. Antiaging benefits of a topical formulation containing coenzyme [Q.sub.I0]: Results of 2 clinical studies. Cosmetic Dermatology 2002; 15:55-60.

(53.) Hamada M, Kazatani Y, Ochi T, et al. Correlation between serum CoQ10 levels and myocardial contractility in hypertensive patients. In: Folkers K. Yamamura Y. eds. Biomedical and Clinical Aspects of Coenzyme [Q.sub.10]Vol 4. Amsterdam: Elsevier Science 1984; 263-270.

(54.) Beal MF, Matthews RT. Coenzyme[Q.sub.10] in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseases. Mol Aspects Med 1997; 18:169-179.

(55.) Anderson CB. Henriksen JE, Hother-Neilsen OH, et al. The effect of coenzyme [Q.sub.10] on blood glucose and insulin requirement in patients with insulin dependent diabetes mellitus. Mol Aspects Med 1997; 18:S307-S309.

(56.) Littarru GP Energy and Defense: Facts and Perspectives on Coenzyme [Q.sub.10] in Biology and Medicine. Rome, Italy: Casa Editrice Scientifica Internazionale; 1994.

(57.) Hoppe U, Bergemann J. Diembeck W, et al. Coenzyme[Q.sub.10], a cutaneous antioxidant and energizer. Biofactors 1999; 9:371-378.

(58.) Ghosh DK, Murthy UV. Antiaging benefits of a topical formulation containing coenzyme [Q.sub.10]: results of 2 clinical studies. Cosmet Dermatol 2002; 15(10):55-60,

(59.) Re O. 2-Dimethylaminuethanul (deanol): a brief review of its clinical efficacy and postulated mechanism of action. Curr Ther Rest Clin Exp 1974; 16:1238-1242.

(60.) Nagy I, Floyd RA. Electron spin predominance spectroscopic dimethylaminoethanol in spin trapping experiments confirming the molecular basis for the biologic effects of centrophenoxine. Arch Gerontol Geriatr 1984; 3:297-310.